Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Skin-to-Skin care may boost survival in tiny newborns

NCT ID NCT07259486

Disease control Sponsor: University of Health Sciences Lahore Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether starting kangaroo mother care (skin-to-skin contact and breastfeeding support) within the first 24 hours helps healthy preterm babies born weighing less than 2000 grams. 100 infants were randomly assigned to early kangaroo care or standard care. The researchers tracked deaths, hospital stay length, and breastfeeding rates to see if early contact improves outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Mar 2022

Finished

Mar 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 hour to 24 hours

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * New admission of singleton or twin (inborn or out-born) * Weight \< 2000 g (as per study scale) * Age 1-24 h old when screening begins * Gestational age \>30 weeks to \<37 weeks * Mother or other caregiver available and willing to provide intervention Exclusion Criteria: * Triplets who are all admitted to the study site * Congenital malformation not compatible with life or needing immediate surgical intervention * Severe jaundice * Seizures * Stable as assessed during cardio-respiratory screening * Severely unstable as assessed during cardio-respiratory screening or died during screening * Severe perinatal asphyxia * Babies require a ventilator or inotropic support * The mother is critically ill or unable to comply with the follow-up schedule * No study bed available * Neonates/mothers enrolled in another research study * No written informed consent from parent or caregiver within 24 h of admission.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low birth weight are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low birth weight Premature Premature birth Preterm infant To compare the outcomes of early kangaroo mother care and standard method care in healthy low birth weight preterm neonates

Contacts and locations

Locations

  • National Hospital and Medical Centre

    Lahore, Punjab Province, 56300, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.